Tag: Dayvigo

All

Latest Research on Lemborexant for Insomnia to Be Presented at AAN Meeting

Topics include lemborexant's impact on daytime alertness in individuals with insomnia, its efficacy in older adults, and the process for transitioning patients from Z-drugs to Lemborexant.

Insomnia Drug Developer Honored with Research and Development Award
Eisai to Present Latest Data on Lemborexant at SLEEP 2023
Why Holistic Treatments for Insomnia Are Becoming More Popular
Eisai Presents Latest Insomnia Research at Virtual SLEEP 2020
A Newly Available Drug for Insomnia Addresses Both Sleep Onset and Maintenance
United States Becomes First Country Where Insomnia Drug DAYVIGO Is Available

All

Eisai Inc Announces US Approval for Insomnia Drug

Japan-based drugmaker Eisai Co’s US subsidiary announced on Sunday that it had received approval from the US Food and Drug Administration for its insomnia treatment in adult patients. The agency approved the drug, Dayvigo,...

Tag: Dayvigo

All

Latest Research on Lemborexant for Insomnia to Be Presented at AAN Meeting

Insomnia Drug Developer Honored with Research and Development Award

Eisai to Present Latest Data on Lemborexant at SLEEP 2023

Why Holistic Treatments for Insomnia Are Becoming More Popular

Eisai Presents Latest Insomnia Research at Virtual SLEEP 2020

A Newly Available Drug for Insomnia Addresses Both Sleep Onset and Maintenance

United States Becomes First Country Where Insomnia Drug DAYVIGO Is Available

All

Eisai Inc Announces US Approval for Insomnia Drug

All

Sorry, No Posts Found

Sorry, No Posts Found

Sleep Review

Our Parent Company

Key Resources

Helpful Links